Swiss contract drug manufacturer Lonza has set new mid-term targets and reaffirmed its 2026 outlook, announcing a focus on drug manufacturing and major growth strategies during its capital markets day ...
GSK plans to cut up to 1,217 jobs in Belgium as part of a three-year restructuring initiative aimed at saving £1.9 billion.
Cipla has issued a voluntary recall of its Fosfomycin Tromethamine Granules for Oral Solution in the US after it failed to ...
A new drug, ANB033, shows promise in treating gluten-caused intestinal damage in celiac patients, providing significant ...
Vir Biotechnology has entered a groundbreaking collaboration with Gilead Sciences, valued at up to $1.88 billion, to develop ...
India’s MedTech manufacturers have made steady progress in recent years, but further development of testing infrastructure ...
Sanofi has avoided a potential fine from the EU by promising to cease disparaging the rival flu vaccine Fluad, made by CSL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results